Form 4: Claritev Director Jason Kap Receives Equity Grant

Director Jason Kap acquired 8,977 restricted stock units in Claritev Corp as part of a standard equity compensation arrangement.

Summary

• Director Jason Kap was granted 8,977 restricted stock units (RSUs) of Class A common stock on April 29, 2026.
• The grant was issued at a price of $0 per share, representing standard equity-based compensation.
• Following this transaction, the director's total beneficial ownership in the company increased to 16,333 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified; this is a routine compensatory filing.

Risks

• Vesting is subject to continued service, creating a dependency on the director's ongoing tenure with the company.

Future Outlook

The RSUs vest on the earlier of the one-year anniversary of the grant date or the date of the next regularly scheduled annual meeting of stockholders, provided the director remains in service.

Industry Context

StockSavvy.ai notes that routine equity grants to directors are standard corporate governance practices intended to incentivize long-term board commitment and shareholder alignment.

Comparison to Industry Standards

• The grant structure follows standard market practices for non-employee director compensation.
• Vesting schedules tied to annual meetings are consistent with typical corporate governance benchmarks for public companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensatory grant.

Next Steps

• Vesting of the 8,977 RSUs on the earlier of April 29, 2027, or the next annual meeting.

Key Dates

Keywords

Claritev, CTEV, Form 4, Insider Trading, Equity Compensation, Director